Thus far, the oncogenic potential of PI3K has largely been attributed to its role in stimulating processes such as cell survival and proliferation, spurring the development of inhibitors of the PI3K pathway as anti-cancer agents3–7. The gene discussed is PIK3CA; the disease is cancer.